Computational Prediction of the Immunomodulatory Potential of RNA Sequences.

[1]  Gajendra P. S. Raghava,et al.  Prediction of Immunomodulatory potential of an RNA sequence for designing non-toxic siRNAs and RNA-based vaccine adjuvants , 2016, Scientific Reports.

[2]  Xing-jie Liang,et al.  RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applications , 2015, Nano today.

[3]  Yu Zhang,et al.  siRNA Versus miRNA as Therapeutics for Gene Silencing , 2015, Molecular therapy. Nucleic acids.

[4]  S. Voss,et al.  A novel RNA‐based adjuvant combines strong immunostimulatory capacities with a favorable safety profile , 2015, International journal of cancer.

[5]  Emil F. Khisamutdinov,et al.  Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles , 2014, Nucleic acids research.

[6]  E. Lander,et al.  Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.

[7]  B. Jessen,et al.  Retina expression and cross-species validation of gene silencing by PF-655, a small interfering RNA against RTP801 for the treatment of ocular disease. , 2012, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[8]  W. Krzyzosiak,et al.  RNAimmuno: a database of the nonspecific immunological effects of RNA interference and microRNA reagents. , 2012, RNA.

[9]  Peter F. Stadler,et al.  ViennaRNA Package 2.0 , 2011, Algorithms for Molecular Biology.

[10]  Firoz Ahmed,et al.  Designing of Highly Effective Complementary and Mismatch siRNAs for Silencing a Gene , 2011, PloS one.

[11]  Celine Vens,et al.  Identifying discriminative classification-based motifs in biological sequences , 2011, Bioinform..

[12]  B. Williams,et al.  Rational design of immunostimulatory siRNAs. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  M. Poidinger,et al.  Sequence determinants of innate immune activation by short interfering RNAs , 2009, BMC Immunology.

[14]  Yann Ponty,et al.  VARNA: Interactive drawing and editing of the RNA secondary structure , 2009, Bioinform..

[15]  C. Cameron,et al.  5'-Triphosphate-Dependent Activation of PKR by RNAs with Short Stem-Loops , 2007, Science.

[16]  Gunther Hartmann,et al.  5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.

[17]  V. Hornung,et al.  siRNA and isRNA: two edges of one sword. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  K. Ishii,et al.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.

[19]  S. Akira,et al.  Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7 , 2005, Nature Medicine.

[20]  J. Goodchild.  Oligonucleotide therapeutics: 25 years agrowing. , 2004, Current opinion in molecular therapeutics.

[21]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.